Viatris Inc (VTRS) Balance Sheet
A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.
Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.
Total Assets Chart for Viatris Inc
Viatris Inc (VTRS) total assets for FY2025 were USD 37.2B, a -10.4% change from FY2024. Viatris Inc's total assets grew from USD 56.0M in 1985 to USD 37.2B in 2025 (66316.2% over 40 years). Total assets compound annual growth rate: 5-year CAGR of -9.6%, 10-year CAGR of 5.3%, 20-year CAGR of 16.1%.
Total Assets (US Dollars)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- $18.64B
- Implied Share Price
- $16.23
- Enterprise Value
- $30.77B
- Revenue (TTM)
- $14.74B
- EBITDA
- $4.29B
- Profit Margin
- -2.79%
- Trailing P/E
- —
- Forward P/E
- 6.49
- Price/Book (MRQ)
- 1.31
- Price/Sales (TTM)
- 1.26
- EV/EBITDA
- 11.74
- EV/Revenue
- 2.09
- Dividend Yield
- 2.99%
- Book Value
- $12.59
- Free Cash Flow (FY2025)
- $1.94B
- Free Cash Flow Yield
- 10.39%
Snapshot as of 16th August 2026 — not point-in-time controlled, may lag the live market by a few days.